MENU

Epilepsy & Seizures

The Latest
More in Epilepsy & Seizures
Case Report: New-Onset Seizures and Brain Lesions in First Trimester image

Case Reports

Challenging Case Report: New-Onset Seizures and Brain Lesions in First Trimester

A woman age 29 and 10 weeks pregnant presented with new-onset seizures and imaging demonstrated previously undiagnosed lesions.

Omar Bushara, BA; Rimas V. Lukas, MD; and Jessica W. Templer, MD

News

11.18.20

FDA Approves Lacosamide for Primary Generalized Tonic-Clonic Seizures and Expanded Pediatric Use
  • KEYWORDS:
  • Epilepsy
  • FDA Approvals
  • primary generalized tonic-clonic seizure
  • Seizures

News

10.26.20

Vatiquinone Proceeds to Phase 2/3 Studies for Treatment of Mitochondrial Epilepsy
  • KEYWORDS:
  • Epilepsy
  • Mitochondrial Epilepsy
  • Phase 2/3 clinical trial
  • vatiquinone

News

10.19.20

FDA Extends Expiration Dating for Diazepam Nasal Spray
  • KEYWORDS:
  • Diazepam
  • FDA Approvals
  • Seizures
Social Determinants of Health Interact With Epilepsy image

Cover Focus

Social Determinants of Health Interact With Epilepsy

Social determinants of health affect epilepsy just as comorbid conditions do.

Magdalena Szaflarski, PhD

Epilepsy and Cognition image

Cover Focus

Epilepsy and Cognition

An Interview with Barbara C. Jobst, MD

Barbara C. Jobst, MD

Epilepsy and Autism image

Cover Focus

Epilepsy and Autism

Because autism is increasingly prevalent and frequently comorbid with epilepsy, children with epilepsy should have autism screening.

Alyssa R. Rosen, MD

Epilepsy and Depression image

Cover Focus

Epilepsy and Depression

The neurologist has a critical role in screening, diagnosis, and treatment.

News

10.05.20

Clinical Trials of Lorcaserin for Treatment of Dravet Syndrome Continue
  • KEYWORDS:
  • Dravet syndrome
  • Epilepsy
  • Epileptic Syndromes
  • Lorcaserin

News

10.01.20

Soticlestat in Rare Epilepsies CDKL5 Deficiency and Dup15q Syndrome Phase 2 Clinical Trials
  • KEYWORDS:
  • CDKL5 Deficiency Disorder
  • Epilepsy
  • Phase 2 clinical trial
  • Soticlestat
September 2020 teaser

Columns

Epilepsy Essentials: EEG Findings Associated With COVID-19

Multiple EEG findings associated with COVID-19 suggest a potential prognostic role.

Michelle L. Dougherty, MD, FAES, FAAN

Anti-<i>N</i>-Methyl D Aspartate Receptor Encephalitis image

Cover Focus

Anti-N-Methyl D Aspartate Receptor Encephalitis

Encephalitis caused by antibodies to the N-methyl-D-aspartate receptor causes symptoms of movement disorders, seizure, and psychiatric disturbances.

Nidhiben Anadani, MD


Autoimmune Movement Disorders in Children image

Cover Focus

Autoimmune Movement Disorders in Children

A clinical approach.

Monideep Dutt, MD; Jamika Hallman-Cooper, MD; Ekta Bery, MD; Mohammed Shahnawaz, MD; and Grace Gombolay, MD

News

09.10.20

Fenfluramine Consistently Reduces Seizures in Children and Young Adults with Dravet Syndrome
  • KEYWORDS:
  • Child neurology
  • Dravet syndrome
  • Epilepsy
  • Fenfluramine
  • Seizures

News

08.31.20

Lacosamide Lowers Risk of Second Primary Generalized Tonic-Clonic Seizure in Clinical Trials
  • KEYWORDS:
  • Epilepsy
  • idiopathic generalized epilepsy
  • lacosamide
  • primary generalized tonic-clonic seizure
  • Seizures
  • Vimpat

News

08.26.20

Soticlestat Reduces Seizure Frequency in Children with Dravet or Lennox-Gastaut Syndrome
  • KEYWORDS:
  • Child neurology
  • Dravet syndrome
  • Lennox-Gastaut Syndrome
  • Seizures
  • Soticlestat
Show More